Scientia Pharmaceutica is published by MDPI from Volume 84 Issue 3 (2016).
Articles in this Issue were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence.
Articles are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Austrian Pharmaceutical Society (Österreichische Pharmazeutische Gesellschaft, ÖPhG).
Sci. Pharm. 2007, 75(2), 55-62; https://doi.org/10.3797/scipharm.2007.75.55 (registering DOI)
The Antimycobacterial Derivatives against Potential Pathogenic Strains: 2-Hydroxy-3-(4-phenylpiperazin-1-yl)-propylphenylcarbamates
Department of Inorganic and Organic Chemistry, Charles University in Prague, Faculty of Pharmacy in Hradec Králové, Heyrovského 1203, CZ-500 05 Hradec Králové, Czech Republic
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojárov 10, SK 832 32 Bratislava. Slovak Republic
Reference Laboratory for Mycobacterium knasasii, Regional Institute of Public Health in Ostrava, Partyzánské nám. 7, CZ 702 00 Ostrava, Czech Republic
Author to whom correspondence should be addressed.
Received: 13 February 2007 / Accepted: 14 March 2007 / Published: 29 June 2007
PDF [300 KB, uploaded 4 January 2017]
Abstract According to our previous study 29 derivatives of 2-hydroxy-3-(4-phenylpiperazin-1-yl)-propylphenylcarbamates were tested for in vitro antimycobacterial activity against potential pathogenic strains Mycobacterium kansasii and Mycobacterium avium. The variations in group of compounds were by the substitution on phenyl rings. The Free-Wilson method was used to evaluate structure-antimycobacterial activity relationships. The advantage of compounds under study is in the activity against M. kansasii.
This is an open access article distributed under the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
Share & Cite This Article
MDPI and ACS Style
Waisser, K.; Doležal, R.; Čižmárik, J.; Malík, I.; Kaustová, J. The Antimycobacterial Derivatives against Potential Pathogenic Strains: 2-Hydroxy-3-(4-phenylpiperazin-1-yl)-propylphenylcarbamates. Sci. Pharm. 2007, 75, 55-62.
Waisser K, Doležal R, Čižmárik J, Malík I, Kaustová J. The Antimycobacterial Derivatives against Potential Pathogenic Strains: 2-Hydroxy-3-(4-phenylpiperazin-1-yl)-propylphenylcarbamates. Scientia Pharmaceutica. 2007; 75(2):55-62.
Waisser, Karel; Doležal, Rafael; Čižmárik, Jozef; Malík, Ivan; Kaustová, Jarmila. 2007. "The Antimycobacterial Derivatives against Potential Pathogenic Strains: 2-Hydroxy-3-(4-phenylpiperazin-1-yl)-propylphenylcarbamates." Sci. Pharm. 75, no. 2: 55-62.
Show more citation formats
Show less citations formats
[Return to top]
For more information on the journal statistics, click here
Multiple requests from the same IP address are counted as one view.